Clinical Tools
Point-of-care tools for clinicians.
Calculators
- Albumin-corrected calcium
- Anion gap (with albumin correction)
- Aortic valve area (continuity equation)
- BMI and body surface area
- Cardiac output (Fick principle)
- CHA₂DS₂-VASc score
- CHADS₂ score
- Corrected QT interval (QTc)
- Creatinine clearance (Cockcroft–Gault)
- Duke treadmill score
- eGFR — CKD-EPI 2021 (creatinine)
- eGFR — MDRD study equation
- Fractional shortening and Teichholz ejection fraction
- HAS-BLED score
- HEART score for chest pain
- Killip classification
- LDL cholesterol — Friedewald equation
- LDL cholesterol — Sampson equation
- Left ventricular mass and geometry
- Mean arterial pressure (MAP)
- Mitral valve area (pressure half-time)
- Pulmonary Embolism Severity Index (PESI)
- Revised Geneva score for pulmonary embolism
- Shunt fraction (Qp/Qs)
- Simplified PESI (sPESI)
- Sodium correction for hyperglycaemia
- Stroke volume & cardiac output (LVOT VTI)
- Systemic and pulmonary vascular resistance
- TIMI risk score for STEMI
- TIMI risk score for UA/NSTEMI
- Wells score for deep vein thrombosis
- Wells score for pulmonary embolism
- 1-2-3-LQTS Risk Calculator
- Adjusted aortic root dimension
- ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Bleeding Risk Score
- Brugada’s algorithm for diagnosing ventricular tachycardia (VT)
- CHADS-VA Bleeding Risk Score
- HCM Risk-SCD Calculator
- HEMORR₂HAGES Bleeding Risk Score
- SYNTAX Score
- SYNTAX Score II
- Vernakalant (Brinavess)
Reference values
- Reference values for adult ECG
- Reference values for pediatric and neonatal ECG
- Heart rate and cycle length conversion table
Echocardiography
- Left ventricular dimension and systolic function
- Left ventricular diastolic function
- Left and right atrium
- Aorta, aortic stenosis (AS), aortic regurgitation (AR)
- Mitral valve
- Tricuspid valve
- Pulmonary valve
- Right ventricle, pulmonary artery, pulmonary artery pressure
Drug manuals
- QT Drugs: Drugs causing QT prolongation, torsade de pointes (TdP) and long QT syndrome (LQTS)
- Inotropes and Vasopressors
- Prasugrel (Effient, Efient, Prasita)
- Ticagrelor (Brilinta, Brilique)
- Clevidipine
- Nicardipine
- Enalaprilat
- Esmolol
- Labetalol
- Metoprolol
- Fenoldopam
- Clonidine
- Nitroglycerin
- Nitroprusside
- Phentolamine
- Hydralazine
- Drug-Induced Cardiotoxicity
- Aspirin (Acetylsalicylic acid)
Treatment summaries
Acute coronary syndromes
- Management of STEMI (ST-Elevation Acute Myocardial Infarction)
- Reperfusion therapy (primary PCI, fibrinolysis) in patients with acute coronary syndromes (STEMI, NSTEMI, unstable angina)
- Reperfusion strategy and fibrinolysis in patients with STEMI
- Management of multivessel disease in patients with ACS undergoing PCI
- Antiplatelet therapy and anticoagulants in STEMI, NSTEMI and unstable angina
- Antithrombotic regimens in patients with ACS with and without an indication for oral anticoagulation
- Lipid lowering therapy after ACS
- Lipid lowering therapy after acute coronary syndromes
Heart failure
- Diagnosis and initial management of heart failure (HFrEF, HFmrEF, HFpEF)
- Management of heart failure with reduced ejection fraction (HFrEF)
- Device therapy in patients with heart failure and reduced ejection fraction (HFrEF)
Arrhythmia and hypertension